Skip to content

Comparison of olive oil and canola oil on the lipid profile in patients with type 2 diabetes

Comparing the effect of canola oil and olive oil on blood lipids, oxidative stress, insulin resistance, blood pressure and inflammation in women with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015062722818N1
Enrollment
75
Registered
2016-02-12
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Nutrional, endocrine and metabolic diseases

Interventions

Intervention 1: Intervention group 1: 30 grams daily olive oil from Famila brand for 8 weeks. Intervention 2: Intervention group 2: 30 grams daily canola oil from Ladan brand for 8 weeks. Intervention
Treatment - Other
Intervention group 1: 30 grams daily olive oil from Famila brand for 8 weeks
Intervention group 2: 30 grams daily canola oil from Ladan brand for 8 weeks
Control group: 30 grams daily sunflower oil from Ladan Brand for 8 weeks

Sponsors

Vice Chancellery for Research of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: female gender; at least 6 months history of diabetes; routine consumption of sunflower oil. Exclusion criteria: needing blood fat-lowering drugs; using insulin; Existence of thyroid disorders; kidney and liver disease; cardiovascular disease; participating in other studies in 6 months before; history of allergies; consumption of corticosteroids, immunosuppressive; NSAIDs; cyclosporine; warfarin; Smoking; alcohol use; Having LDL over 160 and Having TG over 400.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lipid profile. Timepoint: Before and after the intervention. Method of measurement: Blood test.

Secondary

MeasureTime frame
Oxidative stress, insulin resistance, blood pressure and inflammation. Timepoint: Before and after the intervention. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasume Atefi

Shiraz University of Medical Sciences

atefi.masume@yahoo.com+98 25 3292 9575

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 6, 2026